This compound is primarily utilized in the synthesis of pharmaceuticals, particularly in the development of chiral drugs. Its structure, featuring both an amino group and a bromophenyl moiety, makes it a valuable intermediate in the production of active pharmaceutical ingredients (APIs) that target neurological and psychiatric disorders. It is often employed in asymmetric synthesis to create enantiomerically pure compounds, which are crucial for ensuring the efficacy and safety of medications. Additionally, it finds application in research settings for studying receptor interactions and developing new therapeutic agents.